Kaplan-Meyer survival analysis for patients in the longitudinal study. Patients (n = 26) are divided into groups with higher or lower increase of serum sCD14 per time unit compared with median (0.24 μg/mL per 100 days). The Kaplan-Meyer curves indicate that patients with higher sCD14 increase have much shorter survival times than patients with a lower increase in serum sCD14 concentrations. The figure shows cumulative survival plotted against time (until death or censoring). Censored cases are indicated (X).